Ryan Schoenfeld was named chief executive officer of The Mark Foundation for Cancer Research. Schoenfeld will oversee the foundation’s scientific programs, investments, and operations, and will be responsible for shaping how The Mark Foundation allocates the $500 million in additional funding recently committed by its founder (The Cancer Letter, Feb. 18, 2022).
With NCI funding expected to remain flat through fiscal year 2025, health professionals and leaders in oncology should use this time to amp up institutional efforts to collaborate and rebuild trust in science, NCI Director Kimryn Rathmell said.
